Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sclerostin as a new target of diabetes-induced osteoporosis

10 Dec 2024

Abstract excerpt

gene. Sclerostin is a potent soluble inhibitor of the WNT signaling pathway, and is known to inhibit bone formation by inhibiting osteocyte differentiation and function. Currently, sclerostin has been the subject of numerous animal experiments and clinical investigations. By conducting a literature review, we have gained insights into the most recent advancements in research. Patients with both type 1 diabetes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkaline Phosphatase Research Studies
Share to Bone health and osteoporosis research
Share to Bone Metabolism and Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39720253
DOI: 10.3389/fendo.2024.1491066

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sclerostin as a new target of diabetes-induced osteoporosisPMID 39720253Read ↗

The Role of Sclerostin in Bone DiseasesSemantic proximity Read ↗

SclerostinSemantic proximity Read ↗

Endocrine functions of sclerostinSemantic proximity Read ↗

Association of Circulating Sclerostin Levels with Fat Mass and Metabolic Disease—Related Markers in Japanese Postmenopausal WomenSemantic proximity Read ↗

Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetesSemantic proximity Read ↗

Sclerostin: Current Knowledge and Future PerspectivesSemantic proximity Read ↗

Sclerostin: a novel target for intervention in the treatment of osteoporosis.Semantic proximity Read ↗

Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone DiseasesSemantic proximity Read ↗

The Regulation of Bone Metabolism and Disorders by Wnt Signaling.Semantic proximity Read ↗

Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in KuwaitSemantic proximity Read ↗

The sclerostin story: From human genetics to the development of novel anabolic treatment for osteoporosisSemantic proximity Read ↗

Sclerostin: clinical insights in muscle–bone crosstalkSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.